...
首页> 外文期刊>Frontiers in Chemistry >Di- and Tri-nuclear VIII and CrIII Complexes of Dipyridyltriazoles: Ligand Rearrangements, Mixed Valency and Ferromagnetic Coupling
【24h】

Di- and Tri-nuclear VIII and CrIII Complexes of Dipyridyltriazoles: Ligand Rearrangements, Mixed Valency and Ferromagnetic Coupling

机译:二吡啶三唑的二维和三核VIII和CRIII复合物:配体重排,混合式和铁磁耦合

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The first dinuclear and trinuclear chromium(III) and dinuclear vanadium(III) complexes of N4-R-substituted-3,5-di(2-pyridyl)-1,2,4-triazole (Rdpt) ligands have been prepared by solvothermal complexations under inert atmospheres, and characterized. The reactions of CrIII and VIII with adpt (R = amino) resulted in deamination of the ligand and yielded the dinuclear doubly-triazolate bridged complexes [VIII2(dpt-)2Cl4] (1) and [CrIII2(dpt-)2Cl4] (2). In the case of the CrIII complex 2 this bridging results in a rare example of ferromagnetic coupling for a dinuclear CrIII compound. DFT studies confirm that in 2 the ferromagnetic coupling pathways dominate over the antiferromagnetic pathways, whereas in 1 the reverse occurs, consistent with the observed overall antiferromagnetic coupling in that case. It was also found that the use of different additives in the reaction allows the nuclearity of the CrIII product to be manipulated, giving either the dinuclear system, or the first example of a trinuclear circular helicate for a Rdpt complex, [CrIII3(dpt)3Cl6]·1?MeCN·?DCM (3). Reaction of N4-pydpt (R = 4-pyridyl) with VIII led to an unusual shift of the pyridyl substituent from N4 to N1 of the triazole, forming the ligand isomer N1-pydpt, and giving a dinuclear doubly-triazole bridged complex, [VIII2(N1-pydpt)2Cl6]·2MeCN (4). Reaction with CrIII results in loss of the 4-pyridyl ring and a mixture of the di- and trinuclear complexes, 2 and 3. Interestingly, partial oxidation of the VIII in dinuclear complex 4 to vanadyl VIV=O was identified by crystallographic analysis of partially oxidized single crystals, [(VIVO)0.84(VIII)1.16(N1- pydpt)2Cl5.16]·0.84H2O·1.16MeCN (5).
机译:通过溶剂制备了N4-R-取代-3,5-DI(2-吡啶基)-1,2,4-三唑(RDPT)配体的第一种二核和三核铬(III)和二核钒(III)配合物已通过溶剂制备惰性气氛下的络合,并表征。 CRIII和VIII与ADPT(R =氨基)的反应导致配体的脱氨基,得到了二核双三唑桥桥络合物[VIII2(DPT-)2CL4](1)和[CRIII2(DPT-)2CL4](2 )。在CRIII复合物2的情况下,该桥接导致稀有核心CRIII化合物的铁磁偶联的罕见实施例。 DFT研究证实,在2中,铁磁耦合途径支配在反铁磁途径上,而在1中发生逆转,与在这种情况下观察到的总体反铁磁耦合一致。还发现,在反应中使用不同的添加剂允许操纵CRIII产品的核性,给予二核系统,或用于RDPT复合物的三核圆形螺纹的第一实例,[CRIII3(DPT)3CL6 ]·1?mecn·dcm(3)。 N4-PYDPT(R = 4-吡啶基)与VIII的反应导致从三唑的N4至N1的吡啶基取代基的异常偏移,形成配​​体异构体N1-PYDPT,并给予DINUCCOL倍 - 三唑桥接复合物,[ VIII2(N1-PYDPT)2CL6]·2MECN(4)。与CRIII的反应导致4-吡啶族环的损失和二核和三核复合物的混合物,2和3.有趣的是,通过部分地分析鉴定了二核络合物4至viv = O中的VIII的部分氧化,通过部分地分析氧化单晶,[(体内)0.84(VIII)1.16(N1-PYDPT)2Cl5.16]·0.84H2O·1.16mecn(5)​​。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号